Dina Burkitbayeva

Freedom Biosciences Gets $10.5M In Seed Financing For Psychedelics Research, This Is What We Know

Freedom Biosciences achieved a major $10.5 million in a seed financing round in which MBX Capital, PsyMed Ventures, Village Global and The Yale Startup, among others, participated.

New $25M VC Fund Looking At Psychedelics And Neurotechnology To Tackle Global Mental Health Crisis

A new $25 million venture fund is going all-in on psychedelic medicine. PsyMed is an entrepreneur-led VC fund with a focus on psychedelic medicine, precision psychiatry and neurotechnology. The fund’s goal is to support innovative solutions to solve today’s ongoing mental health crisis.